CHTH — CNL Healthcare Properties Income Statement
0.000.00%
- $569.64m
- $1.09bn
- $365.96m
- 73
- 70
- 29
- 58
Annual income statement for CNL Healthcare Properties, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 307 | 295 | 323 | 341 | 366 |
Cost of Revenue | |||||
Gross Profit | 99.9 | 84.9 | 81.1 | 87.8 | 104 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 285 | 296 | 305 | 327 | 335 |
Operating Profit | 21.7 | -0.177 | 17.2 | 14.7 | 30.9 |
Total Net Non Operating Interest Income / Expense | |||||
Total Net Non Operating Interest Income / Expense | |||||
Net Income Before Taxes | 4.16 | -18.7 | 0.128 | -25.1 | -13.8 |
Provision for Income Taxes | |||||
Net Income After Taxes | 3.06 | -22.9 | -0.412 | -25.7 | -14.4 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | 3.91 | -22.9 | -1.45 | -25.7 | -14.5 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 3.91 | -22.9 | -1.45 | -25.7 | -14.5 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.012 | -0.095 | -0.063 | -0.151 | -0.083 |